277 related articles for article (PubMed ID: 8218120)
1. Nucleolar organizer regions in human breast cancer.
Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
Hasnan J; Jayaram G
Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
[TBL] [Abstract][Full Text] [Related]
3. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
Dube MK; Govil A
Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
[TBL] [Abstract][Full Text] [Related]
5. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
Biesterfeld S; Ruoss E; Hufnagl P; Martin H
Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
[TBL] [Abstract][Full Text] [Related]
6. Argyrophilic staining for nucleolar organizer region (AgNOR). A suitable methodology for differential diagnosis of breast lesions?
Sivrides E; Anastasiadis P; von Lüdinghausen M
Zentralbl Pathol; 1992 Apr; 138(2):103-7. PubMed ID: 1610761
[TBL] [Abstract][Full Text] [Related]
7. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
9. The relationship between clinical staging, oestrogen receptor status and silver-binding nucleolar organiser regions (AgNOR) in breast carcinoma.
Ohri AK; Ohri SK; Herbert A; Royle G; Taylor I
Eur J Surg Oncol; 1992 Apr; 18(2):103-7. PubMed ID: 1582501
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of silver binding nucleolar organiser regions (AgNORs) of breast lesions in histological sections and fine needle aspiration smears.
Basu A; Sanyal S; Bhattacharyya A; Bhattacharyya S; Dasgupta S
J Indian Med Assoc; 1997 Aug; 95(8):443-7. PubMed ID: 9492450
[TBL] [Abstract][Full Text] [Related]
11. AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.
Guski H; Hufnagl P; Kaufmann O; Krause M; Winzer KJ
Anal Quant Cytol Histol; 2000 Jun; 22(3):206-12. PubMed ID: 10872036
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
Agarwal PK; Mehrotra A; Chandra T
Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
[TBL] [Abstract][Full Text] [Related]
13. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
[TBL] [Abstract][Full Text] [Related]
14. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry.
Giri DD; Nottingham JF; Lawry J; Dundas SA; Underwood JC
J Pathol; 1989 Apr; 157(4):307-13. PubMed ID: 2715879
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of AgNORs in breast cancer].
Aubele M; Auer G; Jütting U
Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
[TBL] [Abstract][Full Text] [Related]
16. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
[TBL] [Abstract][Full Text] [Related]
17. Value of AgNORS in fine needle aspiration cytology of breast lesions.
Rajeevan K; Aravindan KP; Kumari BC
Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
[TBL] [Abstract][Full Text] [Related]
18. Nucleolar organizer regions in breast cytology material.
Rath-Wolfson L; Hamel I; Halpern M; Klein B; Gal R
Acta Cytol; 1995; 39(5):852-7. PubMed ID: 7571959
[TBL] [Abstract][Full Text] [Related]
19. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
Simha M; Menon M; Doctor V
Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
